Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas.

Oliver JL, Alexander MP, Norrod AG, Mullins IM, Mullins DW.

Pigment Cell Melanoma Res. 2013 Jul;26(4):571-9. doi: 10.1111/pcmr.12091. Epub 2013 Apr 11.

PMID:
23490134
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.

Romas E, Gillespie MT, Martin TJ.

Bone. 2002 Feb;30(2):340-6. Review.

PMID:
11856640
[PubMed - indexed for MEDLINE]
3.

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis.

Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P.

J Biol Chem. 2001 Jun 8;276(23):20659-72. Epub 2001 Mar 23.

PMID:
11274143
[PubMed - indexed for MEDLINE]
Free Article
4.

RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.

Sordillo EM, Pearse RN.

Cancer. 2003 Feb 1;97(3 Suppl):802-12. Review.

PMID:
12548579
[PubMed - indexed for MEDLINE]
Free Article
6.

Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.

J Bone Miner Res. 2001 Jun;16(6):1004-14.

PMID:
11393777
[PubMed - indexed for MEDLINE]
7.

Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand.

Schneeweis LA, Willard D, Milla ME.

J Biol Chem. 2005 Dec 16;280(50):41155-64. Epub 2005 Oct 7.

PMID:
16215261
[PubMed - indexed for MEDLINE]
Free Article
8.

Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.

Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM.

J Bone Miner Res. 2000 Apr;15(4):640-9.

PMID:
10780856
[PubMed - indexed for MEDLINE]
9.

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL.

J Bone Miner Res. 2000 Jan;15(1):2-12. Review.

PMID:
10646108
[PubMed - indexed for MEDLINE]
10.

OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.

De Toni EN, Thieme SE, Herbst A, Behrens A, Stieber P, Jung A, Blum H, Göke B, Kolligs FT.

Clin Cancer Res. 2008 Aug 1;14(15):4713-8. doi: 10.1158/1078-0432.CCR-07-5019.

PMID:
18676739
[PubMed - indexed for MEDLINE]
Free Article
11.

Characterization of synovial cell clones isolated from rheumatoid arthritis patients: possible involvement of TNF-alpha in reduction of osteoprotegerin in synovium.

Zhao B, Takami M, Miyamoto Y, Suzawa T, Yamada A, Mochizuki A, Yasuhara R, Wang X, Inoue T, Namiki O, Sakamoto K, Kamijo R.

Cytokine. 2008 Jan;41(1):61-70. Epub 2007 Dec 20.

PMID:
18083042
[PubMed - indexed for MEDLINE]
12.

The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival.

Pritzker LB, Scatena M, Giachelli CM.

Mol Biol Cell. 2004 Jun;15(6):2834-41. Epub 2004 Apr 2.

PMID:
15064358
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.

Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, Slavin J, Martin TJ, Gillespie MT.

Cancer Res. 2006 Apr 1;66(7):3620-8.

PMID:
16585187
[PubMed - indexed for MEDLINE]
Free Article
14.

Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.

Kubota A, Hasegawa K, Suguro T, Koshihara Y.

J Rheumatol. 2004 Mar;31(3):426-35.

PMID:
14994384
[PubMed - indexed for MEDLINE]
15.

Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors.

Fili S, Karalaki M, Schaller B.

Cancer Lett. 2009 Sep 28;283(1):10-9. doi: 10.1016/j.canlet.2009.01.011. Epub 2009 Feb 6. Review.

PMID:
19201081
[PubMed - indexed for MEDLINE]
16.

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.

Nyambo R, Cross N, Lippitt J, Holen I, Bryden G, Hamdy FC, Eaton CL.

J Bone Miner Res. 2004 Oct;19(10):1712-21. Epub 2004 Jul 7.

PMID:
15355567
[PubMed - indexed for MEDLINE]
17.

Osteoprotegerin is expressed in colon carcinoma cells.

Pettersen I, Bakkelund W, Smedsrød B, Sveinbjørnsson B.

Anticancer Res. 2005 Nov-Dec;25(6B):3809-16.

PMID:
16309167
[PubMed - indexed for MEDLINE]
Free Article
18.

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.

Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I.

J Clin Pathol. 2006 Jan;59(1):56-63.

PMID:
16394281
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death.

Schrader J, Rennekamp W, Niebergall U, Schoppet M, Jahr H, Brendel MD, Hörsch D, Hofbauer LC.

Diabetologia. 2007 Jun;50(6):1243-7. Epub 2007 Apr 19.

PMID:
17443309
[PubMed - indexed for MEDLINE]
20.

Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption.

Kostenuik PJ, Shalhoub V.

Curr Pharm Des. 2001 May;7(8):613-35. Review.

PMID:
11375772
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk